DNA-PK
The DNA-PK holoenzyme comprises a heterodimer of approximately 70- and 80-kDa polypeptides, known as Ku, that binds to DNA strand breaks, recruiting and activating the 470-kDa catalytic subunit, termed DNA-PKcs. Cells lacking DNA-PK are hypersensitive to IR and cross-linking agents and defective in DSB repair. DNA-PK, together with the x-ray cross complementing (XRCC4)/DNA ligase IV complex and the recently identified cofactor Artemis, is specifically required for NHEJ, with about 80% of DNA DSBs repaired by this pathway. DNA-PK can accelerate the repair of IR-, etoposide-, and doxorubicin-induced DSBs, thus conferring resistance to these agents. The inhibition of DNA-PK is an attractive approach for modulating resistance to therapeutically-induced DNA DSBs.
References
1.Furgason JM,et al. Pharmacol Ther. 2013;137(3):298–308.
References
1.Furgason JM,et al. Pharmacol Ther. 2013;137(3):298–308.
Cell Cycle/DNA Damage
ABC(7)
AChR(5)
Antifolate(8)
ATM/ATR(23)
Aurora Kinase(37)
CLK(15)
c-Myc(16)
DHFR(4)
DNA Alkylator(29)
DNA gyrase(7)
DNA Repair Protein(21)
DNA/RNA Synthesis(85)
DNA-PK(11)
GPR(19)
HDAC(111)
Hec1/Nek2(9)
Integrin(38)
LIM Kinase (LIMK)(4)
Mps1/TTK(1)
Nucleoside Antimetabolite/Analog(19)
Other Targets(2)
PARP(30)
PLK(11)
Potassium Channel(55)
RAD51(1)
Rho(5)
ROCK(13)
Telomerase(4)
Topoisomerase(40)
Wee1(2)